Canadian Insurance Stock News

AtkinsRéalis Group walked into this earnings print with a stock that has gone almost nowhere over the past month and quarter, yet it now trades on a trailing P/E of 5.3x, well below construction peers. The market reaction around CA$88 per share looks cautious compared with what the headline numbers show. The real story is profit quality. Reported net margin over the past year sits at 23.2% and earnings growth is very large, but both are heavily shaped by a one off gain of about CA$2.4b...

Canadian Apartment Properties Real Estate Investment Trust went into this earnings release with the unit price under pressure, down over the past week, month and quarter, and closing at CA$34.25 on 7 August. The headline from Q2 is a quieter one on the income statement but louder on the balance sheet. Funds From Operations, the key profit yardstick for a residential REIT, softened only slightly, while total debt sat at about 41.2% of gross book value with weak operating cash flow coverage...

Tenaz Energy stock has been drifting, with a small loss over the past week and a mixed three month stretch, yet the latest quarter lands with a sharp profit reset that the price has not fully reflected. The headline is simple: Q2 flipped from a heavy loss in Q1 to solid earnings, with basic earnings per share at CA$2.71 and net income of CA$89.04 million on CA$156.69 million of revenue. For an oil and gas producer that has carried concerns about earnings quality and debt, this kind of swing...

Curaleaf Holdings stock has drifted over the past three months, down about 18.9%, yet yesterday it closed at CA$12.95 with investors reacting to an earnings print that finally put black ink on the income statement. The market saw an early proof point for the long medical cannabis reset as Curaleaf posted Q2 revenue of US$340.1m and net income of US$12.5m from continuing operations. The headline is simple. Curaleaf just moved from a long stretch of losses into a profitable quarter while...

Cronos Group stock closed at CA$4.32 after the Q2 print, with investors already sitting on a strong 90 day run of about 24%. The key question is whether that move really captures what just happened in the business or if traders are still underestimating the earnings reset. The headline is profit power. Cronos Group delivered Q2 basic earnings per share of US$0.09 on US$53.0m of revenue and turned that into US$32.1m of net income from ongoing operations. That sits on top of a trailing 12 month...

B2Gold stock came into this earnings print already heated, with a 30 day gain of about 31% and the shares closing at CA$7.03 yesterday. The market has been paying up for a story of recovery. The question today is whether the headline profit figure actually justifies that enthusiasm. The emotional driver is simple. B2Gold posted Q2 net income of US$417.3m on revenue of US$789.4m, while only US$41m of that profit sits in adjusted earnings once one off gains are stripped out. If traders focus on...

Medical Facilities heads into the post earnings trade with the stock at CA$15.18, after a rough patch that left it down about 16% over the past month. The market has been skeptical, yet Q2 landed with a clear headline. Core operations printed US$63.1m in revenue and earnings per share of US$0.09, and the trailing P/E multiple sits at 13.1x, well below the broader North American healthcare group. In the short term, the price tells one story. Over a multi year lens, the valuation gap and the...

Quebecor stock has cooled slightly in recent weeks, with the shares down about 1% over the past month, even after a strong 90 day run. That muted reaction sits awkwardly next to what the latest quarter just showed. The headline is earnings power. Quebecor delivered Q2 basic earnings per share of CA$1.21 on revenue of CA$1,440.2m, feeding into trailing 12 month earnings growth of 21.8% and a net profit margin of 16.3%. For investors with a multi year view, the real story now is how that profit...

The market has barely budged on Trisura Group, even though the earnings story is far from quiet. The stock sits near CA$41.60 after a flat week and a weaker month, while the latest quarter delivered basic earnings per share of about CA$0.90 on revenue of roughly CA$823.6m. That combination feeds into trailing twelve month earnings per share of about CA$3.28 and a P/E near 12.6x, which is well below the peer average. The real question for investors now is whether this margin rich insurance...

NFI Group heads into this earnings season with the stock at CA$24.98 after a slightly softer week, yet the latest quarter tells a different story. Q2 2026 delivered revenue of about US$1.03b and net income of US$17.4m, which keeps the turnaround narrative alive for this bus and coach manufacturer. The short term price wobble contrasts with a longer term debate. Forecasts point to faster earnings and revenue growth, while a P/E of 39.5x and interest coverage concerns leave investors weighing...

Cascades went into this earnings print with its stock already on a tear, up about 58% over the past three months and closing at CA$17.02 on August 7. The market priced in a turnaround story and then some. The headline today is that Cascades stayed profitable, with Q2 basic earnings per share of CA$0.21 on CA$1,219m in revenue, but momentum cooled versus Q1. The emotional gap is clear. The share price has been trading as if every quarter would look like Q1, while this report reminds investors...

Knight Therapeutics closed at CA$9.76 after a choppy week where the stock slipped slightly over 7 days and 30 days but still sat higher over 3 months. The headline today is not the share price; it is a Q2 print that mixed a small earnings loss with operating momentum. Revenue reached CA$144.2m in the quarter while adjusted gross margin stepped up to 49%. Management relied on that strength to raise full year revenue and adjusted earnings before interest, taxes, depreciation and amortization...

The market has been warming to WSP Global, with the stock up about 10.7% over the past week and 7.5% over the past month, even as the 3 month return is still in decline. Today’s Q2 release gave that optimism a focal point. The headline is not just higher revenue. It is the earnings engine behind it, with adjusted EBITDA of $815m and margin at 19.1%, which management calls the best Q2 margin since the company listed. For an engineering and consulting stock where cash generation and margin...

Extendicare stock closed at CA$32.44 after a rough few weeks, with the share price down about 12% over the past month, yet the latest earnings tell a more supportive story. Q2 revenue landed at CA$611.0m, helped by the CBI Health acquisition and broader home care growth, while adjusted funds from operations per share climbed strongly to CA$0.448. The short term looks choppy on the screen, but for long term investors the bigger question is whether this step change in scale and cash generation...

Yellow Pages stock came into this earnings release quietly ahead, with a 30 day gain of about 3.5%, and now sits near CA$13.20. The market has treated this as a steady income story, but the headline from the numbers is different. Q2 revenue is CA$47.6m, while net income is CA$3.3m and basic earnings per share are CA$0.25. The board has supported that with a CA$0.25 dividend and a CA$25.3m buyback. The short term story is focused on how long that level of cash return can be sustained. Love the...

Atrium Mortgage Investment’s stock has drifted sideways in recent months, yet today’s earnings ask investors to pick a side. You are looking at a lender trading on an 11.8x P/E while its mortgage portfolio has slipped to CA$860.1m and net income in Q2 came in at CA$11.7m, or CA$0.24 per share. The market’s muted reaction sits awkwardly against a story built around balance sheet strain and portfolio churn rather than a clean growth narrative. This quarter is really about whether that squeeze...

BCE stock comes into this earnings print treading water, with the share price roughly flat over the past month after a modest rebound in the past week. The quick read on today is simple: the market is staring at a low P/E of about 4.7x and a headline net margin near 25% that are flattered by a very large one off gain of about CA$4.2b. The real story for long term holders is different. Analysts expect earnings to decline over the next few years while revenue grows slowly. That tension between...

The market has been edging into Savaria ahead of these results, with the stock up about 4.4% over the past week to CA$30.40, and only a modest slip over the past month. The headline today is profit strength. Q2 net income reached CA$25.2m on CA$245.8m of revenue, while adjusted EBITDA margin came in at 21.1%, supported by a record 39.6% gross margin. Short term traders are reacting to a clean beat on profitability. Long term investors will be weighing that margin profile against management’s...

AirBoss of America stock has drifted lower over the past quarter, yet the latest earnings offered a cleaner signal than the share price suggests. Q2 2026 brought revenue of US$107.9m and a return to positive earnings per share at US$0.09, with net income of US$2.5m, in a business that has been loss making over the last twelve months. The sentiment reckoning for investors now is clear. The stock trades as if past losses still define the story, while this quarter points to a margin and...

Traders have chased Ero Copper higher for weeks, with the stock up roughly 41% over the past month into today’s close at CA$47.78, and Q2 results now put that optimism under a harsher light. The headline is margin power. The business produced US$284.3m in revenue and US$89.5m in net income, leaving investors to judge whether the current P/E of 11.5x, compared with higher industry multiples, reflects underappreciated copper earnings strength or a market that still doubts how durable these...

Canadian Natural Resources stock closed at CA$63.45 after a choppy week that left shares slightly softer over seven days, even as the company reported one of its punchiest quarters on record. The market cooled on the stock just as Q2 2026 earnings and cash generation landed with real weight. The headline is simple. Canadian Natural Resources reported adjusted net earnings of about CA$4.6b and record adjusted funds flow of roughly CA$6.9b, powered by record production. Today’s price reaction...

Markets are wrestling with higher oil prices, unsettled Middle East geopolitics and fresh headlines about AI bubbles, yet corporate earnings from the S&P 500 are running at their strongest pace since 2021. Income investors do not need to sit on the sidelines. This article walks through three high dividend stocks from our screener that appear more exposed to these news catalysts and explains how their cash payouts might fit your portfolio plan. The three stocks below are only a small sample,...

Chartwell Retirement Residences heads into this earnings season with the stock down roughly 5% over the past week and about 7% over the past month, even as the underlying business posts another quarter of revenue growth and stronger operating cash flow. The headline this quarter is not accounting profit. It is the jump in Funds From Operations to CA$90.5m and a 16.7% gain in FFO per unit to CA$0.28, powered by higher occupancy and healthier net operating income. That clash between a softer...

Rogers Sugar came into this earnings print as a high yield, low expectation stock, trading on a P/E of 13.1x that sits well below both the North American food industry and its direct peers. That discount met a set of results that looked more like a margin story than a growth scare. Adjusted net earnings landed at $16m with adjusted EBITDA of $36m and free cash flow over the past year at $90m, enough to keep the long running $0.09 quarterly dividend intact and the investment case focused on...